Bay Street News, April, 2020

NEW YORK, April 29, 2020 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of and […]

PITTSBURGH, April 29, 2020 (GLOBE NEWSWIRE) — II‐VI Incorporated (Nasdaq:IIVI), a leader in engineered materials and photonic solutions for aerospace […]

‘S-HERTOGENBOSCH, the Netherlands, April 29, 2020 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ:ENPH), the world’s leading supplier of solar microinverters, […]

HOLLYWOOD, Fla., April 29, 2020 (GLOBE NEWSWIRE) — NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of […]

WATERTOWN, Mass., April 29, 2020 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing […]

End of Phase 2 FDA meeting scheduled to discuss the path forward for IFX-1 in Hidradenitis SuppurativaInitial promising results reported […]

HANGZHOU, China, April 29, 2020 (GLOBE NEWSWIRE) — UTStarcom (“UT” or “the Company”) (NASDAQ:UTSI), a global telecommunications infrastructure provider, today […]

BEDFORD, Mass., April 29, 2020 (GLOBE NEWSWIRE) — Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today upcoming […]

CAMBRIDGE, Mass., April 29, 2020 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery […]

SHANGHAI, China, April 29, 2020 (GLOBE NEWSWIRE) — ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”) is relying on the […]